Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imescard for Chronic Constipation and Hemorrhoids
NCT00861562Phase 3Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Imescard water smartweed in chronic constipation and Hemorrhoids (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Reduction in colonic transit time at Day 19. Status: unknown.
02
Drugs
Imescard water smartweed
03
Conditions
chronic constipationHemorrhoids
Beyond the preview
Go deeper on NCT00861562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861562.